Impact of a ketogenic diet on metabolic parameters in patients with obesity or overweight and with or without type 2 diabetes: a meta-analysis of randomized controlled trials.
Open accessThe DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index; 15 of the 52 sources its claims cite were checked for support.
Abstract
The aim of this meta-analysis was to explore the efficacy of a ketogenic diet in metabolic control in patients with overweight or obesity and with or without type 2 diabetes. Embase, PubMed, and Cochrane Library were searched for randomized controlled trials that enrolled patients with overweight or obesity on a ketogenic diet for metabolic control. Fourteen studies were included in meta-analysis. The effects of ketogenic diets on glycemic control were greater for diabetic patients relative to those of low-fat diets, indicated by lower glycated hemoglobin (SMD, −0.62; p < 0.001) and homeostatic model assessment index (SMD, −0.29; p = 0.02), while comparable effects were observed for nondiabetic patients. Ketogenic diets led to substantial weight reduction (SMD, −0.46; p = 0.04) irrespective of patients’ diabetes status at baseline and improved lipid profiles in terms of lower triglyceride (SMD, −0.45; p = 0.01) and greater high-density lipoprotein (SMD, 0.31; p = 0.005) for diabetic patients. Other risk markers showed no substantial between-group difference post intervention. Our study findings confirmed that ketogenic diets were more effective in improving metabolic parameters associated with glycemic, weight, and lipid controls in patients with overweight or obesity, especially those with preexisting diabetes, as compared to low-fat diets. This effect may contribute to improvements in metabolic dysfunction-related morbidity and mortality in these patient populations.
Overview
CoChat Summary
TL;DR
This meta-analysis of 14 RCTs found that ketogenic diets improved glycemic control, weight loss, and some lipid parameters in patients with overweight/obesity, especially those with preexisting type 2 diabetes, compared with low-fat-based comparator diets. Effects on blood pressure, CRP, and serum creatinine were comparable to comparator diets.
Key findings
- In diabetic patients, ketogenic diets lowered HbA1c (SMD, −0.62; 95% CI, −0.89 to −0.35; p < 0.001; I² = 0%) and HOMA index (SMD, −0.29; 95% CI, −0.54 to −0.04; p = 0.02; I² = 0%) versus comparator diets; nondiabetic patients showed no significant glycemic decrease.
- Overall, ketogenic diets lowered fasting glucose (SMD, −0.25; 95% CI, −0.50 to −0.00; I² = 52%) and HbA1c (SMD, −0.48; 95% CI, −0.69 to −0.27; I² = 23%); mean between-group HbA1c changes were −0.5% in diabetic patients and −0.42% overall (both p < 0.001).
- Weight reduction was greater with ketogenic diets (SMD, −0.46; 95% CI, −0.90 to −0.03; I² = 78%); mean between-group weight changes were −7.78 kg in diabetic patients and −3.81 kg overall. BMI and waist circumference reductions approached but did not reach significance (p = 0.08 and p = 0.09).
- In diabetic patients, ketogenic diets lowered triglycerides (SMD, −0.45; 95% CI, −0.80 to −0.10; I² = 59%) and raised HDL (SMD, 0.31; 95% CI, 0.10 to 0.52; I² = 0%); in nondiabetic patients, total cholesterol (SMD, 0.34; 95% CI, 0.08 to 0.61) and LDL (SMD, 0.35; 95% CI, 0.09 to 0.61) increased. Other risk markers showed no substantial between-group difference.
Methods
- PRISMA-guided systematic review and meta-analysis; Embase, PubMed, and Cochrane Library searched through 11 February 2020 for RCTs of ketogenic diets in patients with overweight or obesity, with or without type 2 diabetes, versus comparator diets (primarily low-fat-based).
- Fourteen RCTs were included, enrolling 734 participants: 444 diabetic patients and 290 nondiabetic patients; intervention durations varied across outcomes (e.g., 3–12 months for glycemic control, 4 weeks–12 months for weight, and 4 days–2 years for lipids).
- Continuous outcomes were pooled as weighted standardized mean differences with 95% CIs; fixed- or random-effects models were chosen based on I²; subgroup analyses were performed by baseline type 2 diabetes status; RevMan 5.3 was used, with Cochrane risk-of-bias and GRADE assessments and Begg’s/Egger’s tests for publication bias.
Limitations
- The paper states that included RCTs had different study designs and control diets (mostly low-fat-based), intervention durations varied, some subgroup analyses may have been underpowered due to small sample size, and surrogate markers were used rather than patient-important endpoints such as cardiovascular/renal events or mortality.
- Evident from the text: only one included study reported adverse effects; two studies had high risk of attrition bias and one had high risk of bias from baseline triglyceride imbalance; heterogeneity was high for weight (I² = 78%) and triglycerides (I² = 59%).
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
9 Valid · 0 Not valid · 21 Not checked · 70 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In 2019, American Diabetes Association (ADA) newly endorsed low-carbohydrate diet as part of medical nutrition therapy options in diabetic patients based on the study results denoting enhanced glycemic control with a very low-carbohydrate diet inducing nutritional ketosis in T2DM patients [27,50,51,52].”
§ Impact of a Ketogenic Diet on Metabolic Parameters in Patients with Obesity or Overweight and with or without Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials > 4. Discussion
What the sources say
- Could not verifycites [27] Saslow, 2017, Twelve-month outcomes of a randomized trial of a moderate-carbohydrate versus very low-carbohydrate diet in overweight adults with type 2 diabetes mellitus or prediabetes, Nutr. Diabetes sourceExperimental — accuracy not yet measured
The Introduction and Discussion report the trial’s findings on glycemic control, but neither addresses an ADA endorsement. Searches for ADA recommendations and medical nutrition therapy found no passage about a 2019 decision; the cited paper was published in 2017. (LLM, conf=0.78)
- Not checked yetcites [50] Sainsbury, 2018, Effect of dietary carbohydrate restriction on glycemic control in adults with diabetes: A systematic review and meta-analysis, Diabetes Res. Clin. Pract. source
- Not checked yetcites [51] American Diabetes Association (2019). 5. Lifestyle management: Standards of medical care in diabetes-2019. Diabetes Care, 42, S46–S60. source
- Partly supportedcites [52] Hallberg, 2018, Effectiveness and safety of a novel care model for the management of type 2 diabetes at 1 year: An open-label, non-randomized, controlled study, Diabetes Ther. sourceExperimental — accuracy not yet measured
The Methods (Continuous Care Intervention) describe carbohydrate restriction to achieve nutritional ketosis, and the Discussion reports improved HbA1c after one year. The paper does not report a 2019 ADA endorsement or establish that the ADA acted based on these results. (LLM, conf=0.87)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“weight loss is reported to attenuate or reverse obesity-induced insulin resistance [48,49]”
§ Impact of a Ketogenic Diet on Metabolic Parameters in Patients with Obesity or Overweight and with or without Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials > 4. Discussion
What the sources say
- Supportedcites [48] Ye, 2013, Mechanisms of insulin resistance in obesity, Front. Med. source
The Abstract of Ye (2013) lists weight loss among 'the effective therapies such as weight loss, exercise, and caloric restriction [that] all reduce ATP in insulin sensitive cells', i.e. therapies that act on obesity-induced insulin resistance. The Summary (p. last section) states the energy-centred mechanism 'explains insulin sensitivity in response to weight loss, exercise, and caloric restriction where energy surplus is attenuated', and the Inflammation section notes 'Negative energy balance in the body has been known for long time to improve insulin sensitivity in the models of exercise, calorie restriction and weight loss'. The Mitochondrial dysfunction section also refers to 'improvement of insulin sensitivity from weight loss'. Together these support the attributed point that weight loss attenuates/reverses obesity-induced insulin resistance; the paper frames it as an established, reported effect rather than its own trial. (LLM, conf=0.86)
- Not checked yetcites [49] Vidal, 2002, Updated review on the benefits of weight loss, Int. J. Obes. Metab. Disord. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“nutritional ketosis has shown the capacity to reduce the use of hypoglycemic agents in diabetic patients [32,52]”
§ Impact of a Ketogenic Diet on Metabolic Parameters in Patients with Obesity or Overweight and with or without Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials > 4. Discussion
What the sources say
- Partly supportedcites [32] Westman, 2008, The effect of a low-carbohydrate, ketogenic diet versus a low-glycemic index diet on glycemic control in type 2 diabetes mellitus, Nutr. Metab. sourceExperimental — accuracy not yet measured
Our copy supports the medication-reduction half: the Abstract Results (Results, p. n/a) state 'Diabetes medications were reduced or eliminated in 95.2% of LCKD vs. 62% of LGID participants (p < 0.01)', and the Discussion (and Conclusion) describe insulin elimination alongside improved glycemic control in overweight/obese adults with type 2 diabetes over 24 weeks. However, the paper attributes the effect to lower carbohydrate intake (significance remained after adjustment for weight loss, Discussion), not to nutritional ketosis as a mechanism — urinary ketones appear only as an adherence measure (Methods, 'Adherence'). The claim's generalisation to 'diabetic patients' also exceeds this source's type 2, adult, completer population. (LLM, conf=0.72)
- Supportedcites [52] Hallberg, 2018, Effectiveness and safety of a novel care model for the management of type 2 diabetes at 1 year: An open-label, non-randomized, controlled study, Diabetes Ther. source
Hallberg et al. (2018) is a 1-year T2D study whose intervention was explicitly built to achieve and sustain nutritional ketosis (Methods, Continuous Care Intervention: goal 0.5–3.0 mmol L−1 blood BHB). Its Results and Abstract report that usage of all diabetes medications excluding metformin fell from 56.9 ± 3.1% to 29.7 ± 3.0% (P < 1.0 × 10−16), with insulin reduced or eliminated in 94% of users and sulfonylureas entirely eliminated, versus no significant change in usual care. The Discussion (Effectiveness) states 'HbA1c improved concurrent with medication reductions prescribed for blood glucose-lowering,' tying the glycemic improvement under ketosis to the reduced agent use. The one nuance is that the source credits the multicomponent care model (including provider-managed downward titration) rather than isolating ketosis as the sole cause, but the attributed content — ketosis achieved in diabetic patients with markedly reduced hypoglycemic-agent use — is stated in our copy. (LLM, conf=0.82)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Our meta-analysis for glycemic control incorporated 4 studies [27,28,30,34] that had intervention duration of at least 8 months or longer”
§ Impact of a Ketogenic Diet on Metabolic Parameters in Patients with Obesity or Overweight and with or without Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials > 4. Discussion
What the sources say
- Supportedcites [27] Saslow, 2017, Twelve-month outcomes of a randomized trial of a moderate-carbohydrate versus very low-carbohydrate diet in overweight adults with type 2 diabetes mellitus or prediabetes, Nutr. Diabetes source
The citation identifies this trial as one of the four studies in the citing authors’ meta-analysis; the count of four is their own description, not a finding attributed to this paper. The Methods (Assessments) and Results (Table 1) show glycemic-control measurements, including HbA1c, at 12 months—longer than the stated eight-month minimum. (LLM, conf=0.91)
- Supportedcites [28] Saslow, 2017, An online intervention comparing a very low-carbohydrate ketogenic diet and lifestyle recommendations versus a plate method diet in overweight individuals with type 2 diabetes: A randomized controlled trial, J. Med. Internet Res. source
The Methods > Measures section describes this as a 32-week online dietary intervention with HbA1c measured at baseline, week 16, and week 32. That is approximately eight months, making this paper an appropriate citation for one of the studies described; it cannot establish the citing authors’ count of four studies. (LLM, conf=0.84)
- Not checked yetcites [30] Tay, 2018, Effects of an energy-restricted low-carbohydrate, high unsaturated fat/low saturated fat diet versus a high-carbohydrate, low-fat diet in type 2 diabetes: A 2-year randomized clinical trial, Diabetes Obes. Metab. source
- Not checked yetcites [34] Yancy, 2010, A randomized trial of a low-carbohydrate diet vs orlistat plus a low-fat diet for weight loss, Arch. Intern. Med. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In overall patients, the ketogenic diet appeared more effective in lowering FG (SMD, −0.25; 95% CI, −0.50 to −0.00; I2 = 52%; low quality evidence)”
§ Impact of a Ketogenic Diet on Metabolic Parameters in Patients with Obesity or Overweight and with or without Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials > 3. Results > 3.3. The Effects of a Ketogenic Diet on Glycemic Control
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
53 more claims
Create a free account to see all 100 claims and to verify the 37 references still open.
- Probably not a substantial claim. 27
- It may state two separate claims as one. 24
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Seventeen meta-analyses were included (Fig. 1 and Additional file 2: Table S3) [1, 2, 15–17, 34–45].”
From Effects of ketogenic diet on health outcomes: an umbrella review of meta-analyses of randomized clinical trials (2023) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“While some evidence demonstrates weight loss and improved CVD risk factors with other popular weight-loss approaches (eg, time-restricted eating, intermittent fasting, ketogenic diet),70–72 clinical practice guidelines have not endorsed these strategies, and they may require dietitian support.”
From Obesity Management in Adults: A Review (2023) · cites this paper as [72]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Impact of a Ketogenic Diet on Metabolic Parameters in Patients with Obesity or Overweight and with or without Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials > 4. Discussion
“The mean post-intervention improvement in triglyceride levels was −35.12 mg/dL (p = 0.002) and −20.65 mg/dL (p = 0.02) in overall patients.”
§ Impact of a Ketogenic Diet on Metabolic Parameters in Patients with Obesity or Overweight and with or without Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials > 3. Results > 3.5. The Effects of a Ketogenic Diet on Lipid Panel
“The mean between-group difference in triglyceride changes was −35.12 mg/dL (p = 0.002) in diabetic patients and −20.65 mg/dL (p = 0.02) in overall patients.”
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042 · cited 1×
“The Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) was used to guide our methodology and to prepare this article [17,18].”
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305 · cited 1×
“…low, and very low in e ff ect estimates for individual outcomes, based on the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach, in which studies are evaluated on five aspects: precision, consistency of e ff ect, directness, risk of bias, and publication bias [19,20].”
MethodShamseer, L., Moher, D., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., Stewart, L. A., & the PRISMA-P Group (2015) · BMJ · doi:10.1136/bmj.g7647 · Cited by 13,120 · cited 1×
“The Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) was used to guide our methodology and to prepare this article [17,18].”
MethodGrading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
European Guidelines for Obesity Management in Adults
Yumuk, V., Tsigos, C., Fried, M., Schindler, K., Busetto, L., Micic, D., & Toplak, H. (2015) · Obesity Facts · doi:10.1159/000442721 · Cited by 3,432 · cited 1×
“The current treatment guidelines for obesity recommend dietary restriction, specifically caloric restriction, as the first nutritional modification for weight loss [4].”
BackgroundThe Epidemiology of Obesity: A Big Picture
Hruby, A., & Hu, F. B. (2015) · PharmacoEconomics · doi:10.1007/s40273-014-0243-x · Cited by 2,916 · cited 2×
“…with obesity is constantly growing, with approximately 38% and 20% of world’s adult population to be overweight and obese by 2030, respectively, and the proportion of population with overweight and obesity is anticipated to be even higher at approximately over 85% in the United States [2].”
BackgroundChildhood obesity: causes and consequences
Bhadoria, A., Sahoo, K., Sahoo, B., Choudhury, A., Sofi, N., & Kumar, R. (2015) · Journal of Family Medicine and Primary Care · doi:10.4103/2249-4863.154628 · Cited by 1,985
Dyslipidemia in obesity: Mechanisms and potential targets
Klop, B., Elte, J., & Cabezas, M. (2013) · Nutrients · doi:10.3390/nu5041218 · Cited by 1,665 · cited 1×
“Obesity has a clear correlation with the incidence of cardiovascular disorders including hypertension, coronary artery disease, heart failure and sudden death, and many patients with insulin resistance, the main etiology of T2DM, tend to have high triglyceride and low HDL levels [53–55].”
BackgroundImpact of intermittent fasting on health and disease processes
Mattson, M. P., Longo, V. D., & Harvie, M. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.10.005 · Cited by 1,187 · cited 1×
“Besides, inducing starvation via dietary regimens of alternate-day fasting [38] or intermittent fasting [39] has shown to reduce caloric intake and improve health markers related to cardiovascular risk in populations irrespective of obesity status.”
Background
Research works printed but not linked: 1
- Osler, 1923, Diabetes mellitus, The Principles and Practice of Medicine, Volume 1, 421
Cited by
Obesity Management in Adults: A Review
Elmaleh-Sachs, A., Schwartz, J. L., Bramante, C. T., Nicklas, J. M., Gudzune, K. A., & Jay, M. (2023) · JAMA · doi:10.1001/jama.2023.19897 · Cited by 813
Zhu, H., Bi, D., Zhang, Y., Kong, C., Du, J., Wu, X., Wei, Q., & Qin, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00831-w · Cited by 399
“Similarly, a meta-analysis of randomized controlled trials (RCTs) demonstrated that, compared to low-fat diets, KD more effectively improved the metabolic parameters associated with glycemic, weight, and lipid control in obese participants, especially those with preexisting diabetes.(117) Plasma lipids constitute the…”
MethodKetone bodies: from enemy to friend and guardian angel
Kolb, H., Kempf, K., Röhling, M., Lenzen-Schulte, M., Schloot, N. C., & Martin, S. (2021) · BMC Medicine · doi:10.1186/s12916-021-02185-0 · Cited by 361
“All metabolic effects of ketogenic diets were similar in obese nondiabetic study participants, but of lower magnitude [102].”
BackgroundThe Role of Ketogenic Diet in the Treatment of Neurological Diseases
Dyńka, D., Kowalcze, K., & Paziewska, A. (2022) · Nutrients · doi:10.3390/nu14235003 · Cited by 215
“Taking into account the strongly hypoglycaemic effect of a ketogenic diet and the evident insulin-concentration-reducing effect [51,52], it seems reasonable that a ketogenic diet would have a favourable effect on the prevention of the deposition of amyloid plaques or a reduction in their number.”
BackgroundVancells Lujan, P., Viñas Esmel, E., & Sacanella Meseguer, E. (2021) · Nutrients · doi:10.3390/nu13051442 · Cited by 209
“of total daily caloric intake (20–50 g of carbohydrate/day) [133], although the specific macronutrient composition may vary.”
BackgroundA Heart-Healthy Diet for Cardiovascular Disease Prevention: Where Are We Now?
Diab, A., Dastmalchi, L. N., Gulati, M., & Michos, E. D. (2023) · Vascular Health and Risk Management · doi:10.2147/vhrm.s379874 · Cited by 176
“Individuals with insulin resistance or diabetes cannot properly metabolize glucose in the blood, which makes excess carbohydrates intake unfavorable in terms of glycemic control, and as such, following a VLC diet helps improve glycemic control and HbA1c.(79,80) Other studies evaluating VLC diets in the management of o…”
BackgroundInfluentialImplicating the effect of ketogenic diet as a preventive measure to obesity and diabetes mellitus
Kumar, S., Behl, T., Sachdeva, M., Sehgal, A., Kumari, S., Kumar, A., Kaur, G., Yadav, H. N., & Bungau, S. (2021) · Life Sciences · doi:10.1016/j.lfs.2020.118661 · Cited by 173
Developing dietary interventions as therapy for cancer
Taylor, S. R., Falcone, J. N., Cantley, L. C., & Goncalves, M. D. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00485-y · Cited by 185
Sethi, S., Wakeham, D. E., Ketter, T. A., Hooshmand, F., Bjornstad, J., Richards, B. J., Westman, E. C., Krauss, R. M., & Saslow, L. R. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.115866 · Cited by 194
“Ketogenic diets have been shown to reduce cardiovascular risk in patients with metabolic abnormalities, such as insulin resistance (Athinarayanan et al., 2020; Choi et al., 2020; Kosinski and Jornayvaz, 2017).”
The Ketogenic Diet and Cardiovascular Diseases
Dyńka, D., Kowalcze, K., Charuta, A., & Paziewska, A. (2023) · Nutrients · doi:10.3390/nu15153368 · Cited by 134
Jing, T., Zhang, S., Bai, M., Chen, Z., Gao, S., Li, S., & Zhang, J. (2023) · Nutrients · doi:10.3390/nu15143156 · Cited by 139
“(1) Low-carbohydrate diet: less than 25% carbohydrate intake of total energy intake [31]; (2) Moderate-carbohydrate diet: 25% to 45% carbohydrate intake of total energy intake [31]; (3) Ketogenic diet: 5% to 10% carbohydrate intake of total energy intake, replacing the remaining with dietary fat and adequate protein (…”
Patikorn, C., Saidoung, P., Pham, T., Phisalprapa, P., Lee, Y. Y., Varady, K. A., Veettil, S. K., & Chaiyakunapruk, N. (2023) · BMC Medicine · doi:10.1186/s12916-023-02874-y · Cited by 101
“%) glycemic profile outcomes (i.e., hemoglobin A1c [HbA1c], fasting plasma glucose, fasting insulin, and homeostatic model assessment of insulin resistance [HOMA-IR]), 6 (5”
BackgroundInfluentialRafiullah, M., Musambil, M., & David, S. K. (2022) · Nutrition Reviews · doi:10.1093/nutrit/nuab040 · Cited by 86
Dietary patterns and cardiometabolic health: Clinical evidence and mechanism
Wang, W., Liu, Y., Li, Y., Luo, B., Lin, Z., Chen, K., & Liu, Y. (2023) · MedComm · doi:10.1002/mco2.212 · Cited by 100
The Effect of Ketogenic Diet on Shared Risk Factors of Cardiovascular Disease and Cancer
Mohammadifard, N., Haghighatdoost, F., Rahimlou, M., Rodrigues, A. P. D. S., Gaskarei, M. A. K., Okhovat, P., de Oliveira, C. M., Silveira, É. A., & Sarrafzadegan, N. (2022) · Nutrients · doi:10.3390/nu14173499 · Cited by 76
SGLT2 Inhibition for Cardiovascular Diseases, Chronic Kidney Disease, and NAFLD
Ala, M. (2021) · Endocrinology · doi:10.1210/endocr/bqab157 · Cited by 75
Carbohydrate restriction for diabetes: rediscovering centuries-old wisdom
Lennerz, B. S., Koutnik, A. P., Azova, S., Wolfsdorf, J. I., & Ludwig, D. S. (2021) · Journal of Clinical Investigation · doi:10.1172/jci142246 · Cited by 66
Ketogenic Diet: A Review of Composition Diversity, Mechanism of Action and Clinical Application
Malinowska, D., & Żendzian‐Piotrowska, M. (2024) · Journal of Nutrition and Metabolism · doi:10.1155/2024/6666171 · Cited by 82
“Te KD led to signifcant weight loss and improvement in lipid parameters by reducing the levels of triglycerides and increasing HDL cholesterol, but it was also associated with elevated values of LDL cholesterol—a relatively greater increase was noted among patients without diabetes [184].”
BackgroundJi, J., Fotros, D., Sohouli, M. H., Velu, P., Fatahi, S., & Liu, Y. (2023) · Nutrition Reviews · doi:10.1093/nutrit/nuad175 · Cited by 74
Molecular Mechanisms Underlying the Bioactive Properties of a Ketogenic Diet
Murakami, M., & Tognini, P. (2022) · Nutrients · doi:10.3390/nu14040782 · Cited by 59
“A meta-analysis of randomized controlled trials in humans revealed that a KD is effective at improving metabolic parameters associated with glycemic status, weight, and lipids in obese patients compared with low-fat diets [99].”
BackgroundDyńka, D., Kowalcze, K., Ambrożkiewicz, F., & Paziewska, A. (2023) · Nutrients · doi:10.3390/nu15030500 · Cited by 58
Lennerz, B. S., Mey, J. T., Henn, O., & Ludwig, D. S. (2021) · Current Developments in Nutrition · doi:10.1093/cdn/nzab133 · Cited by 70
“In meta-analyses of trials for T2DM, low- compared with high-carbohydrate diets produced greater weight loss (40– 42), lower HbA1c (40–46), and reduction in usage of glucose-lowering medications (41, 43, 45, 46), consistent with our observations.”
Jeziorek, M., Szuba, A., Sowicz, M., Adaszyńska, A., Kujawa, K., & Chachaj, A. (2023) · Nutrients · doi:10.3390/nu15112619 · Cited by 57
“[17] found in a meta-analysis of 14 studies that a ketogenic diet for 3 to 12 months was more effective for glycemic control, as indicated by a significant reduction in HbA1c and HOMA values for diabetic patients.”
BackgroundZaki, H. A., Iftikhar, H., Bashir, K., Gad, H., Fahmy, A. S., & Elmoheen, A. M. (2022) · Cureus · doi:10.7759/cureus.25528 · Cited by 45
“For example, a meta-analysis of seven RCTs showed that diabetic patients had a significant weight loss of 7.78 kg after consuming KDs [26].”
MethodInfluentialChung, J. Y., Kim, O. Y., & Song, J. (2021) · Nutrition Reviews · doi:10.1093/nutrit/nuab118 · Cited by 50
“metabolism in the brain is linked to cognitive function(46) as well as imbalanced glucose metabolism.(47) The ketone bodies AcAc and b-hydroxybutyrate are used as the main energy source in the brain during ketosis(48) (Figure 2(14,41)).”
BackgroundLuo, W., Zhang, J., Xu, D., Zhou, Y., Qu, Z., Yang, Q., & Lv, Q. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1092031 · Cited by 44
“Considerable evidence now suggests the effectiveness of ketogenic diets in regulating glucose metabolism (14, 45).”
BackgroundMethodAdherence to Low-Carbohydrate Diets in Patients with Diabetes: A Narrative Review
Kumar, N. K., Merrill, J. D., Carlson, S., German, J., & Yancy, W. S., Jr. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s292742 · Cited by 51
Dietary patterns to promote cardiometabolic health
Pagidipati, N. J., Taub, P. R., Ostfeld, R. J., & Kirkpatrick, C. F. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01061-7 · Cited by 50
“However, beyond 12 months, weight loss was not significantly different with carbohydrate-restricted diets compared with higher-carbohydrate diets 43,54–56 .”
InfluentialKetogenic diet in children and adolescents: The effects on growth and nutritional status
Corsello, A., Trovato, C. M., Profio, E. D., Cardile, S., Campoy, C., Zuccotti, G., Verduci, E., & Diamanti, A. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106780 · Cited by 50
“7) Others • Overweight and obesity*[45,46]”
Nutritional Regulation of Human Brown Adipose Tissue
Suchacki, K. J., & Stimson, R. H. (2021) · Nutrients · doi:10.3390/nu13061748 · Cited by 49
Makievskaya, C. I., Popkov, V. A., Andrianova, N. V., Liao, X., Zorov, D. B., & Plotnikov, E. Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032576 · Cited by 41
Pharmacological treatment of MASLD: contemporary treatment and future perspectives
Drygalski, K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136518 · Cited by 39
Epigenetic modifications in obesity‐associated diseases
Long, Y., Mao, C., Liu, S., Tao, Y., & Xiao, D. (2024) · MedComm · doi:10.1002/mco2.496 · Cited by 59
Ketogenic diet and multiple health outcomes: an umbrella review of meta-analysis
Chen, S., Su, X., Feng, Y., Li, R., Liao, M., Fan, L., Liu, J., Chen, S., Zhang, S., Cai, J., et al. (2023) · Nutrients · doi:10.3390/nu15194161 · Cited by 41
“The quality of the reviews was assessed using AMSTAR-2, 3 with high-quality ratings [64,65,67], 10 with low-quality ratings [5,18,24,56,58,59,64,66,73,74], and 10 with critically low-quality ratings (Tables 1 and 2) [9,57,60–62, The quality of the reviews was assessed using AMSTAR-2, 3 with…”
InfluentialLow-Carbohydrate High-Fat Diet: A SWOC Analysis
Nuwaylati, D. A., Eldakhakhny, B. M., Bima, A. I. H., Sakr, H. F., & Elsamanoudy, A. Z. (2022) · Metabolites · doi:10.3390/metabo12111126 · Cited by 42
“Moreover, obesity is one of IR’s significant consequences and comorbidities [15,16].”
BackgroundSmolensky, I. V., Zajac-Bakri, K., Odermatt, T. S., Brégère, C., Cryan, J. F., Guzman, R. G., Timper, K., & Inta, D. (2023) · Scientific Reports · doi:10.1038/s41598-023-43587-9 · Cited by 36
Ketogenic Diets for Body Weight Loss: A Comparison with Other Diets
Dyńka, D., Rodzeń, Ł., Rodzeń, M., Pacholak-Klimas, A., Ede, G., Sethi, S., Łojko, D., Bartoń, K., Berry, K., Deptuła, A., et al. (2025) · Nutrients · doi:10.3390/nu17060965 · Cited by 47
“…one of these meta-analyses concluded that the ketogenic diet, compared to low-fat (carbohydrate-based) diets, is more effective in managing metabolic parameters responsible for controlling glycaemia, body weight, and even lipids in overweight and obese patients—especially those with T2DM [133].”
Zhao, H., Jin, H. Y., Xian, J., Zhang, Z., Shi, J., & Bai, X. (2022) · Nutrients · doi:10.3390/nu14194192 · Cited by 38
“diabetes, obesity, hypercholesterolemia, and polycystic ovary syndrome [4,5].”
BackgroundAdherence to Low-Carbohydrate Diets in Patients with Diabetes: A Narrative Review
Kumar, N., Merrill, J. D., Carlson, S., German, J., & Yancy, W. S. (2022) · Dove Medical Press (Taylor and Francis Group) · Cited by 33
Choi, A. H., Delgado, M., Chen, K. Y., Chung, S. T., Courville, A. B., Turner, S. A., Yang, S. B., Airaghi, K. J., Dustin, I. M., McGurrin, P. M., et al. (2024) · BMC Neurology · doi:10.1186/s12883-024-03603-5 · Cited by 37
“These category des-ignations were determined based on literature showing greater metabolic benefits of a ketogenic diet including weight loss, glycemic and lipid effects in subjects with metabolic syndrome or diabetes [40].”
Ketone Bodies in Diabetes Mellitus: Friend or Foe?
Veneti, S., Grammatikopoulou, M. G., Kintiraki, E., Mintziori, G., & Goulis, D. G. (2023) · Nutrients · doi:10.3390/nu15204383 · Cited by 40
“Today, numerous meta-analyses have shown efficacy of the KD in reducing body weight and other obesity indices (BMI and waist circumference) [47,51,89–94], improving HbA1c levels, and improving blood lipid profiles [47,51,89–95] (Table 4).”
BackgroundLi, S., Du, Y. N., Meireles, C. L., Sharma, K., Qi, L., Castillo, A., & Wang, J. (2023) · Nutrition and Diabetes · doi:10.1038/s41387-023-00246-2 · Cited by 35
“Recent meta-analyses of randomized controlled trials consistently demonstrated the ef fi cacy of KD for individuals with overweight/obesity and T2D compared to usual diet or other recommended diets for diabetes management [14 – 16].”
BackgroundMethodWang, Z., Chen, T., Wu, S., Dong, X., Zhang, M., & Ma, G. (2024) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2024.04.021 · Cited by 42
Giannakogeorgou, A., & Roden, M. (2024) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17848 · Cited by 30
Merovci, A., Finley, B., HANSIS-DIARTE, A. A., Neppala, S., Abdul‐Ghani, M. A., Cersósimo, E., Triplitt, C. L., & DeFronzo, R. A. (2024) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2024-004199 · Cited by 41
“Multiple studies 13–19 and meta-analyses/reviews 20–23 have demonstrated that a low carbohydrate, ketogenic diet can enhance glycemic control in obese individuals with T2D.”
Choy, K. Y. C., & Louie, J. C. Y. (2023) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2023.102905 · Cited by 40
Aamri, K. S. A., Alrawahi, A. H., Busaidi, N. A., Githi, M. S. A., Jabri, K. A., Balushi, F. A., Ronquillo-Talara, R., Balushi, S. A., & Waly, M. I. (2022) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2022.02.110 · Cited by 27
Beneficial Effects of the Ketogenic Diet on Nonalcoholic Fatty Liver Disease (NAFLD/MAFLD)
Dyńka, D., Rodzeń, Ł., Rodzeń, M., Łojko, D., Kraszewski, S., Ibrahim, A., Hussey, M., Deptuła, A., Grzywacz, Ż., Ternianov, A., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13164857 · Cited by 29
“Even if body weight reduction is at a similar level compared to a high-carb diet (a similar calorie deficit), a KD can additionally improve metabolic parameters while being safe to use [47,72–74].”
BackgroundWang, H., Lv, X., Zhao, S., Yuan, W., Zhou, Q., Sadiq, F. A., Zhao, J., Lu, W., & Wu, W. (2023) · Nutrients · doi:10.3390/nu15194163 · Cited by 25
“…(KD) to modify the diversity and species composition of the gut microbiota in individuals with various health conditions, including obesity [26], type 2 diabetes [42], cancer [43], epilepsy [44–46], and cognitive impairment [47,48], and Alzheimer’s disease [49], as well as healthy individuals [50].”
BackgroundLeung, L. Y. L., Tam, H. L., & Ho, J. K.-M. (2025) · Clinical Nutrition · doi:10.1016/j.clnu.2025.01.017 · Cited by 31
Rajewski, P., Cieściński, J., Rajewski, P., Suwała, S., Rajewska, A., & Potasz, M. (2025) · Biomedicines · doi:10.3390/biomedicines13010217 · Cited by 38
The proteomic effects of ketone bodies: implications for proteostasis and brain proteinopathies
García‐Velázquez, L., & Massieu, L. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1214092 · Cited by 22
“In the long-term KD causes secondary effects, such as a loss of weight, especially relevant in aged patients, and increased blood levels of LDL cholesterol (Fuehrlein et al., 2004; Choi et al., 2020; Kolb et al., 2021).”
BackgroundDietary Risk Factors and Eating Behaviors in Peripheral Arterial Disease (PAD)
Cecchini, A. L., Biscetti, F., Rando, M. M., Nardella, E., Pecorini, G., Eraso, L. H., DiMuzio, P. J., Gasbarrini, A., Massetti, M., & Flex, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810814 · Cited by 37
“Loss of weight and fat mass directly benefits diabetic management [42], resulting in improved glycemic control with an expected reduction in glycated hemoglobin [41].”
BackgroundEmerging Nonpharmacologic Interventions to Treat Diabetic Peripheral Neuropathy
Enders, J. D., Elliott, D., & Wright, D. E. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0158 · Cited by 25
“In recent years, there have been several case reports (Chandrasekaran and Rani, 2020; Dressler et al, 2010; To´th, 2014) and larger studies (Choi et al, 2020; Goday et al, 2016; Westman et al, 2008) in humans highlighting the efficacy and safety of ketogenic diets in diabetic patients.”
Ketogenic Diet in Heart Failure
Kodur, N., Yurista, S. R., Province, V. M., Rueth, E., Nguyen, C. T., & Tang, W. H. W. (2023) · JACC Heart Failure · doi:10.1016/j.jchf.2023.05.009 · Cited by 20
Intermittent fasting with ketogenic diet: A combination approach for management of chronic diseases
Arora, N., Pulimamidi, S., Yadav, H., Jain, S., Glover, J., Dombrowski, K. E., Hernandez, B., Sarma, A. K., & Aneja, R. (2023) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2023.01.024 · Cited by 18
Metabolic Strategies in Healthcare: A New Era
Phillips, M. C. L. (2022) · Aging and Disease · doi:10.14336/ad.2021.1018 · Cited by 21
“Multiple systematic reviews of randomized controlled trials have generally demonstrated a beneficial impact of LCDs and KDs on insulin resistance [119-122].”
BackgroundNoakes, T. D. (2021) · Open Heart · doi:10.1136/openhrt-2021-001680 · Cited by 19
Balestra, F., Luca, M. D., Panzetta, G., Palieri, R., Shahini, E., Giannelli, G., Pergola, G. D., & Scavo, M. P. (2025) · Current Obesity Reports · doi:10.1007/s13679-025-00622-2 · Cited by 15
“Conversely, additional studies have confirmed that the KD may help reduce the morbidity and mor - tality associated with metabolic dysfunction in these patient populations [118].”
The Cardioprotective Effects of Nutritional Ketosis: Mechanisms and Clinical Implications
Venturini, C., Mancinelli, L., Matacchione, G., Olivieri, F., & Antonicelli, R. (2024) · Nutrients · doi:10.3390/nu16234204 · Cited by 16
Bengin, E., KIRTEPE, A., Çınar, V., Akbulut, T., Russo, L., Aydemir, İ., Yücedal, P., Aydın, S., & Migliaccio, G. M. (2024) · Medicina · doi:10.3390/medicina60071118 · Cited by 21
“Moreover, VLCKD resulted in more significant long-term weight loss compared to the low-fat diet, suggesting that it is a potential alternative option for obesity management [31].”
BackgroundKetogenic Diet Regulates Cardiac Remodeling and Calcium Homeostasis in Diabetic Rat Cardiomyopathy
Lee, T.-I., Trang, N. N., Lee, T., Higa, S., Kao, Y., Chen, Y., & Chen, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216142 · Cited by 20
“Several studies have confirmed that a KD has beneficial effects on enhancing body weight loss [54], glycemic control [55], and other cardiovascular risk factors such as blood pressure [56] and lipid profiles [57,58].”
BackgroundKetogenic Diet and Vitamin D Metabolism: A Review of Evidence
Detopoulou, P., Papadopoulou, S. Κ., Voulgaridou, G., Dedes, V., Tsoumana, D., Gioxari, A., Gerostergios, G., Detopoulou, M., & Panoutsopoulos, G. I. (2022) · Metabolites · doi:10.3390/metabo12121288 · Cited by 18
“A meta-analysis of randomized controlled trials showed that a KD was more effective than low-fat diets in improving glycemic, weight, and lipid profiles in obese subjects, especially in those with comorbidities such as diabetes [38].”
MethodLiu, Y., Bharmal, S. H., Kimita, W., & Petrov, M. S. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01571-z · Cited by 14
“Some studies demonstrated either an increase [31] or no significant change in total [32, 33] and LDL cholesterol [34] levels following a ketogenic diet.”
BackgroundDu, Y. N., Wang, J., Li, S., Dennis, B., Meireles, C. L., Siddiqui, N., Patel, D. I., Gelfond, J., Li, C., Faruqui, S. H. A., et al. (2022) · Contemporary Clinical Trials · doi:10.1016/j.cct.2022.106845 · Cited by 12
“This pilot clinical trial addresses this research gap by testing the efficacy of a 6-month, technologyassisted, ketogenic diet lifestyle intervention on CRM health (e.g., weight, lipid profile, glycemic control and renal health) using both traditional and innovative omics indicators in overweight/obese adults with/wit…”
InfluentialZhou, J., Lu, Y., Jia, Y., Lu, J., Jiang, Z., & Chen, K. (2022) · Molecular Medicine · doi:10.1186/s10020-021-00429-6 · Cited by 21
Unlocking the potential: very-low-energy ketogenic therapy in obesity-related disorders
Simancas‐Racines, D., Reytor-González, C., Zambrano, A. K., Annunziata, G., Am, C., Verde, L., Frías-Toral, E., Guerra, C. V., & Hidalgo, R. (2025) · Food and Agricultural Immunology · doi:10.1080/09540105.2024.2442368 · Cited by 13
“Similarly, Choi et al. (2020) demonstrated significant reductions in HbA1c levels and HOMA-IR index in overweight or obese patients with T2D, indicating the effectiveness of VLEKT in improving glycemic control.”
García-Belenguer, S., Grasa, L., Palacio, J., Moral, J., & Rosado, B. (2023) · Veterinary Sciences · doi:10.3390/vetsci10040245 · Cited by 14
“or obesity, especially in those with preexisting diabetes [30].”
BackgroundZaki, H. A., Iftikhar, H., Abdalrubb, A., Al-Marri, N. D. R., Abdelrahim, M. G., Fayed, M., Elgassim, M. A., & Elarref, M. (2022) · Cureus · doi:10.7759/cureus.30879 · Cited by 21
“78 kg for patients in the KD group [37].”
BackgroundGreenwell, A. A., Saed, C. T., Dakhili, S. A. T., Ho, K. L., Gopal, K., Chan, J. S. F., Kaczmar, O. O., DYER, S. A., Eaton, F., Lopaschuk, G. D., et al. (2022) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00435.2021 · Cited by 13
ChatGPT ‐4o for Weight Management: Comparison of Different Diet Models
Karahan, T. Ö., & Kenger, E. B. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.70639 · Cited by 20
Bachar, A., & Birk, R. Z. (2025) · Current Nutrition Reports · doi:10.1007/s13668-025-00634-3 · Cited by 14
“…sugar levels [23, 31], • Hormonal changes that impact hunger, including reduced ghrelin, and increased levels of glucagon-like peptide-1 (GLP1), adiponectin, and cholecysto-kinin (CCK), all of which contribute to a decreased perception of hunger [2, 3, 5, 6, 9, 11, 13, 14, 16, 21, 23, 31, 32].”
InfluentialLee, S., Bae, J., Jo, D. R., Lee, M., Lee, Y., Kang, E. S., Soo, B., & Lee, B. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1124576 · Cited by 15
Impact of Food Addiction in Therapy Response in Obesity and Eating Disorders
Camacho‐Barcia, L., Munguía, L., Gaspar‐Pérez, A., Jiménez‐Múrcia, S., & Fernández‐Aranda, F. (2022) · Current Addiction Reports · doi:10.1007/s40429-022-00421-y · Cited by 13
“Recent results have shown that this dietary approach has had beneficial effect on metabolic parameters associated with obesity and type 2 diabetes, including weight control and management of lipid and glycaemic parameters [33].”
BackgroundChianelli, M., Armellini, M., Carpentieri, M. S., Coccaro, C., Cuttica, C. M., Fusco, A., Marucci, S., Nelva, A., Nizzoli, M., Ponziani, M. C., et al. (2024) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303282327240507184902 · Cited by 15
Thaker, V., Kwee, L. C., Chen, H., Bahnson, J. L., Ilkayeva, O., Muehlbauer, M. J., Wolfe, B. M., Purnell, J. Q., Pi-Sunyer, X., Newgard, C. B., et al. (2023) · Obesity · doi:10.1002/oby.23943 · Cited by 10
“Although higher levels of ketone bodies, especially BHB, have been associated with the release of reactive oxygen species in the mitochondria, other studies show that ketogenic diets and ketone bodies can be beneficial to the organism in the long term [24,25].”
BackgroundSheffler, J., Kiosses, D. N., He, Z., Arjmandi, B. H., Akhavan, N. S., Klejc, K., & Naar, S. (2023) · Nutrients · doi:10.3390/nu15102329 · Cited by 13
Root Cause for Metabolic Syndrome and Type 2 Diabetes
Baskin, R. G., & Alfakara, D. (2022) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2022.10.007 · Cited by 15
You, Y., Ni, H., Ma, Q., Jiang, L., Cai, J., He, W., Lin, X., Li, K., Wang, Z., Yan, W., et al. (2025) · Nutrition and Diabetes · doi:10.1038/s41387-025-00391-w · Cited by 15
Szendi, K., Murányi, E., Hunter, N., & Németh, B. (2024) · Foods · doi:10.3390/foods13020248 · Cited by 12
Wu, W., Zhou, Q., Yuan, P., Qiao, D., Deng, S., Cheng, H., & Ren, Y. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s365192 · Cited by 12
Walker, L., Smith, N., & Delon, C. (2021) · BMJ Nutrition Prevention & Health · doi:10.1136/bmjnph-2020-000219 · Cited by 10
Saturated fat in an evolutionary context
Garnås, E. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-024-02399-0 · Cited by 13
“Ketogenic and very-low-carbohydrate diets can produce rapid and meaningful fat loss [215, 216], and have been suggested to hold therapeutic promise for some diseases [217].”
Toivio, L., Launonen, H., Lindén, J., Lehto, M. J., Vapaatalo, H., Salmenkari, H., & Korpela, R. (2023) · Nutrients · doi:10.3390/nu16010018 · Cited by 8
“This diet has been used to treat drug-resistant epilepsy for a century [9], in addition to which it is studied for conditions ranging from neurodegenerative diseases [10] to diabetes [11] with encouraging results.”
BackgroundEffect of d ‐β‐Hydroxybutyrate‐(R)‐1,3 Butanediol on Appetite Regulation in People with Prediabetes
Liu, Y., Bharmal, S. H., Kimita, W., & Petrov, M. S. (2022) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202200615 · Cited by 8
Titcomb, T. J., Liu, B., Wahls, T. L., Snetselaar, L., Shadyab, A. H., Tabung, F. K., Saquib, N., Arcan, C., Tinker, L. F., Wallace, R. B., et al. (2022) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2022.12.004 · Cited by 12
Are the Modern Diets for the Treatment of Obesity Better than the Classical Ones?
Koliaki, C. C., & Katsilambros, N. L. (2022) · Endocrines · doi:10.3390/endocrines3040052 · Cited by 9
“A meta-analysis of 14 RCTs, comparing ketogenic diets with low-fat diets in subjects with and without T2DM, produced in summary the following findings: (i) ketogenic diets followed for 3–12 months are more effective than low-fat diets for improving glycemic control and insulin sensitivity in patients with T2DM, but th…”
BackgroundResultNutrition and Gut–Brain Pathways Impacting the Onset of Parkinson’s Disease
Terenzi, D., Muth, A.-K., & Park, S. Q. (2022) · Nutrients · doi:10.3390/nu14142781 · Cited by 12
Beretta, M. V., Flores, C., Colameo, G. F., Echabe, L. W., & Busnello, F. M. (2024) · Nutrition Reviews · doi:10.1093/nutrit/nuae123 · Cited by 9
Khdher, S. N., Mohammed, S., Muhammed, K., & Ismael, A. (2024) · Cureus · doi:10.7759/cureus.57920 · Cited by 7
“Nonetheless, the investigation by Choi et al. [5] found that the ketogenic diet's impact on kidney function tests was equivalent to that of the control group.”
BackgroundLow-carbohydrate diets in type 1 diabetes: balancing benefits and risks
Hancock, M., Burns, K. A., Gan, S. K., & Chew, G. T. (2023) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000797 · Cited by 10
Acquired acrodermatitis enteropathica from a ketogenic diet
Osmani, S., Smidt, A. C., Phan, C. M., & Johnson, D. W. (2021) · JAAD Case Reports · doi:10.1016/j.jdcr.2021.01.016 · Cited by 7
The role of intermittent fasting and ketogenic diet in metabolic syndrome and type 2 diabetes
Delrue, C., Speeckaert, R., & Speeckaert, M. M. (2025) · Acta Clinica Belgica · doi:10.1080/17843286.2025.2540287 · Cited by 9
“Also reductions in triglyceride levels and BMI were noted, supporting the utility of KDs in improving both glycemic and lipid profiles [47].”
Xiao, G. L., Wang, T., Kuang, J., Li, W., Liu, H., Ma, S. P., Sohouli, M. H., Fatahi, S., Li, C., & Zou, S. (2024) · Acta Diabetologica · doi:10.1007/s00592-024-02362-6 · Cited by 8
“While the KD, if prescribed without calorie restriction, does not have a significant effect on weight loss [17, 60].”
Javier, D. A., Manubolu, V. S., Norwitz, N. G., Kinninger, A., Aldana-Bitar, J., Ghanem, A. M., Ahmad, K., Vicuna, W. D., Hamidi, H., Bagheri, M., et al. (2024) · Coronary Artery Disease · doi:10.1097/mca.0000000000001395 · Cited by 7
“…and atherogenic dyslipidemia [1,4] The majority of the clinical trials involving lipid-lowering therapy have a high preponderance of patients considered ‘metabolically unhealthy’, as determined by the presence of criteria for metabolic syndrome [5,6] or insulin resistance-associated comorbidities.”
BackgroundAnalysis of the management and therapeutic performance of diabetes mellitus employing special target
Sun, H., & Lin, X.-Y. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i12.1721 · Cited by 10
A Case of Severe Metabolic Acidosis in the Setting of a Strict Ketogenic Diet
Ward, K., Ramsay, J., & Vu, B. J. (2023) · Cureus · doi:10.7759/cureus.38741 · Cited by 6
“The populations that may benefit from the ketogenic diet include patients with obesity [3], Alzheimer's disease [4], drug-resistant epilepsy [5], and those undergoing treatment of certain cancers [6].”
BackgroundTay, M. H. J., Yap, Q. V., Lim, S. L., Ong, Y. W. Y., Wee, V. C. H. T., & Khoo, C. M. (2025) · Nutrients · doi:10.3390/nu17152541 · Cited by 5
“It has a very low carbohydrate intake, moderate protein content, and high fat content, which induces nutritional ketosis and facilitates weight loss [10,11].”
Practical guidelines for addressing common questions and misconceptions about the ketogenic diet
Rice, S. M., & Reynolds, D. B. (2025) · Journal of Metabolic Health · doi:10.4102/jmh.v8i1.113 · Cited by 6
Effect of ketogenic diet on exercise tolerance and transcriptome of gastrocnemius in mice
Zhang, J., Chen, B., & Zou, K. (2023) · Open Life Sciences · doi:10.1515/biol-2022-0570 · Cited by 7
“of type 2 diabetes mellitus by producing ketone bodies and using ketone bodies for energy [10].”
Background
Metadata
- Authors
- Choi, Y. J., Jeon, S.-M., & Shin, S.
- Affiliations
- Hallym University Medical Center (KR)
- Ajou University (KR)
- Corresponding author
- Shin, Sooyoung
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2020-07-06
- Volume
- 12
- Issue
- 7
- Pages
- 2005
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC7400909
- OpenAlex
- W3038345563
- Semantic Scholar
- c9e4dfc137872628059f83f074d65d093a6e4861
- Cited by
- 193
- References
- 64
- Citations by year
- 2026: 19 · 2025: 32 · 2024: 40 · 2023: 46 · 2022: 40 · 2021: 14 · 2020: 2
- FWCI
- 3.25
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Research Foundation
- Ajou University
- Korea Health Industry Development Institute (HI17C0640)
- National Research Foundation of Korea (2017R1C1B5015912)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
- Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- ketogenic diet, obesity, overweight, type 2 diabetes, glycemic control, HbA1c, HOMA-IR, weight loss, lipid profile, triglycerides, HDL cholesterol, metabolic parameters
- MeSH terms
- Adolescent, Adult, Aged, Blood Glucose, Body Weight, Diabetes Mellitus, Type 2, Female, Humans, Lipids, Male, Middle Aged, Obesity, Randomized Controlled Trials as Topic, Overweight, Diet, Ketogenic, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.